Meeting Archive:
An ASBMR Webinar on Choosing Osteoporosis Treatment

To listen to the recording and view the slides that were presented, click on the recording link on the right side of this screen. 
Supported by an education donation provided by Amgen

Meeting Description:

There are several treatments for osteoporosis, many of which have been shown to decrease fracture risk.  However, there are no head-to-head studies that show clearly superior fracture risk reduction.  The purpose of the webinar is to help the clinician decide which therapy is likely to work best for patients with osteoporosis – based on randomized, controlled trials, reviews, and comparative effectiveness analyses.  Side effects of osteoporosis therapy will also be covered because of the need to assess both benefits and risks. 

As a result of this webinar participants will be able to:
  • Be familiar with the pros and cons of standard therapy for osteoporosis.
  • Understand that differences in efficacy among bisphosphonates, teriparatide, and denosumab in reducing fracture risk are small.
  • Be able to make therapeutic decisions in specific patients, based on risks and benefits.
Date: Thu, Sep 26, 2013
Time: 12:00 PM EDT
Duration: 1 hour
Host(s): American Society for Bone and Mineral Research
 Presenter Information
Robert A. Adler, M.D.
Speaker Photo

Dr. Robert A. Adler is Chief of Endocrinology at the McGuire Veterans Affairs Medical Center in Richmond, Virginia and Professor of Internal Medicine at Virginia Commonwealth University School of Medicine.  His research interests include screening men for osteoporosis, osteoporosis in patients with mobility disorders, and improving osteoporosis care in high risk patient populations.  Dr. Adler was a member of the ASBMR Atypical Femoral Fractures Task Force and the Endocrine Society Male Osteoporosis Guidelines Committee.  He is a member of ASBMR Council.